BioAge Labs, Inc.

General ticker "BIOA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $455.9M (TTM average)

BioAge Labs, Inc. follows the US Stock Market performance with the rate: 48.1%.

Estimated limits based on current volatility of 3.3%: low 21.68$, high 23.16$

Factors to consider:

  • Total employees count: 62 (-3.1%) as of 2025
  • Company does not operate outside North America (retrieved using AI)
  • Top business risk factors: Clinical trial failure, Regulatory and compliance, Capital raising, Commercialization challenges, Labor/talent shortage/retention
  • Current price 25.3% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [6.80$, 18.07$]
  • 2026-12-31 to 2027-12-31 estimated range: [4.22$, 11.96$]

Similar symbols

Short-term BIOA quotes

Long-term BIOA plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $8.99MM
Operating Expenses $48.40MM $78.19MM $101.78MM
Operating Income $-48.40MM $-78.19MM $-92.78MM
Non-Operating Income $-15.45MM $7.08MM $12.18MM
Interest Expense $7.79MM $2.37MM $0.70MM
R&D Expense $33.89MM $59.04MM $73.97MM
Income(Loss) $-63.85MM $-71.11MM $-80.61MM
Net Income(Loss)* $-63.85MM $-71.11MM $-80.61MM
Stockholders Equity $-173.40MM $323.13MM $272.05MM
Assets $25.92MM $358.23MM $294.89MM
Operating Cash Flow $-37.36MM $-51.52MM $-81.63MM
Capital expenditure $0.17MM $0.37MM $0.72MM
Investing Cash Flow $-0.27MM $-0.37MM $-95.22MM
Financing Cash Flow $34.94MM $381.20MM $11.47MM
Earnings Per Share** $-1.87 $-1.98 $-2.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.